Frontiers in Cellular and Infection Microbiology (Jul 2022)

The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection

  • Lorenza Romani,
  • Federica Del Chierico,
  • Gabriele Macari,
  • Stefania Pane,
  • Maria Vittoria Ristori,
  • Valerio Guarrasi,
  • Simone Gardini,
  • Giuseppe Rubens Pascucci,
  • Nicola Cotugno,
  • Nicola Cotugno,
  • Carlo Federico Perno,
  • Paolo Rossi,
  • Paolo Rossi,
  • Alberto Villani,
  • Stefania Bernardi,
  • Andrea Campana,
  • Paolo Palma,
  • Paolo Palma,
  • Lorenza Putignani,
  • the CACTUS Study Team,
  • Francesca Calo` Carducci,
  • Caterina Cancrini,
  • Sara Chiurchiù,
  • Marta Ciofi degli Atti,
  • Laura Cursi,
  • Renato Cutrera,
  • Carmen D’Amore,
  • Patrizia D’Argenio,
  • Maria A. De Ioris,
  • Maia De Luca,
  • Andrea Finocchi,
  • Laura Lancella,
  • Emma Concetta Manno,
  • Elena Morrocchi,
  • Paola Pansa,
  • Libera Sessa,
  • Paola Zangari

DOI
https://doi.org/10.3389/fcimb.2022.908492
Journal volume & issue
Vol. 12

Abstract

Read online

This is the first study on gut microbiota (GM) in children affected by coronavirus disease 2019 (COVID-19). Stool samples from 88 patients with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and 95 healthy subjects were collected (admission: 3–7 days, discharge) to study GM profile by 16S rRNA gene sequencing and relationship to disease severity. The study group was divided in COVID-19 (68), Non–COVID-19 (16), and MIS-C (multisystem inflammatory syndrome in children) (4). Correlations among GM ecology, predicted functions, multiple machine learning (ML) models, and inflammatory response were provided for COVID-19 and Non–COVID-19 cohorts. The GM of COVID-19 cohort resulted as dysbiotic, with the lowest α-diversity compared with Non–COVID-19 and CTRLs and by a specific β-diversity. Its profile appeared enriched in Faecalibacterium, Fusobacterium, and Neisseria and reduced in Bifidobacterium, Blautia, Ruminococcus, Collinsella, Coprococcus, Eggerthella, and Akkermansia, compared with CTRLs (p < 0.05). All GM paired-comparisons disclosed comparable results through all time points. The comparison between COVID-19 and Non–COVID-19 cohorts highlighted a reduction of Abiotrophia in the COVID-19 cohort (p < 0.05). The GM of MIS-C cohort was characterized by an increase of Veillonella, Clostridium, Dialister, Ruminococcus, and Streptococcus and a decrease of Bifidobacterium, Blautia, Granulicatella, and Prevotella, compared with CTRLs. Stratifying for disease severity, the GM associated to “moderate” COVID-19 was characterized by lower α-diversity compared with “mild” and “asymptomatic” and by a GM profile deprived in Neisseria, Lachnospira, Streptococcus, and Prevotella and enriched in Dialister, Acidaminococcus, Oscillospora, Ruminococcus, Clostridium, Alistipes, and Bacteroides. The ML models identified Staphylococcus, Anaerostipes, Faecalibacterium, Dorea, Dialister, Streptococcus, Roseburia, Haemophilus, Granulicatella, Gemmiger, Lachnospira, Corynebacterium, Prevotella, Bilophila, Phascolarctobacterium, Oscillospira, and Veillonella as microbial markers of COVID-19. The KEGG ortholog (KO)–based prediction of GM functional profile highlighted 28 and 39 KO-associated pathways to COVID-19 and CTRLs, respectively. Finally, Bacteroides and Sutterella correlated with proinflammatory cytokines regardless disease severity. Unlike adult GM profiles, Faecalibacterium was a specific marker of pediatric COVID-19 GM. The durable modification of patients’ GM profile suggested a prompt GM quenching response to SARS-CoV-2 infection since the first symptoms. Faecalibacterium and reduced fatty acid and amino acid degradation were proposed as specific COVID-19 disease traits, possibly associated to restrained severity of SARS-CoV-2–infected children. Altogether, this evidence provides a characterization of the pediatric COVID-19–related GM.

Keywords